Italia markets closed

ILMN Jun 2024 95.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
21,320,00 (0,00%)
Alla chiusura: 01:13PM EDT
Schermo intero
Chiusura precedente21,32
Aperto21,00
Denaro14,10
Lettera21,70
Prezzo d'esercizio95,00
Scadenza2024-06-21
Min-Max giorno21,00 - 21,32
Contratto - Min-MaxN/D
Volume6
Open Interest77
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera